Correlation Between Fate Therapeutics and Mirati Ther
Can any of the company-specific risk be diversified away by investing in both Fate Therapeutics and Mirati Ther at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fate Therapeutics and Mirati Ther into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fate Therapeutics and Mirati Ther, you can compare the effects of market volatilities on Fate Therapeutics and Mirati Ther and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fate Therapeutics with a short position of Mirati Ther. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fate Therapeutics and Mirati Ther.
Diversification Opportunities for Fate Therapeutics and Mirati Ther
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Fate and Mirati is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Fate Therapeutics and Mirati Ther in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mirati Ther and Fate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fate Therapeutics are associated (or correlated) with Mirati Ther. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mirati Ther has no effect on the direction of Fate Therapeutics i.e., Fate Therapeutics and Mirati Ther go up and down completely randomly.
Pair Corralation between Fate Therapeutics and Mirati Ther
If you would invest 137.00 in Fate Therapeutics on November 27, 2024 and sell it today you would lose (1.00) from holding Fate Therapeutics or give up 0.73% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 0.0% |
| Values | Daily Returns |
Fate Therapeutics vs. Mirati Ther
Performance |
| Timeline |
| Fate Therapeutics |
| Mirati Ther |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Fate Therapeutics and Mirati Ther Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Fate Therapeutics and Mirati Ther
The main advantage of trading using opposite Fate Therapeutics and Mirati Ther positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fate Therapeutics position performs unexpectedly, Mirati Ther can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mirati Ther will offset losses from the drop in Mirati Ther's long position.| Fate Therapeutics vs. Atara Biotherapeutics | Fate Therapeutics vs. Sana Biotechnology | Fate Therapeutics vs. Caribou Biosciences | Fate Therapeutics vs. Arcus Biosciences |
| Mirati Ther vs. Sarepta Therapeutics | Mirati Ther vs. Krystal Biotech | Mirati Ther vs. Day One Biopharmaceuticals | Mirati Ther vs. Amylyx Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |